The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways: Implications in Diabetes Mellitus–Associated Obesity and Vascular Dysfunction
Abstract
We reported aldosterone as a novel adipocyte-derived factor that regulates vascular function. We aimed to investigate molecular mechanisms, signaling pathways, and functional significance of adipocyte-derived aldosterone and to test whether adipocyte-derived aldosterone is increased in diabetes mellitus–associated obesity, which contributes to vascular dysfunction. Studies were performed in the 3T3-L1 adipocyte cell line and mature adipocytes isolated from human and mouse (C57BL/6J) adipose tissue. Mesenteric arteries with and without perivascular fat and mature adipocytes were obtained from obese diabetic db/db and control db/+ mice. Aldosterone synthase (CYP11B2; mRNA and protein) was detected in 3T3-L1 and mature adipocytes, which secrete aldosterone basally and in response to angiotensin II (Ang II). In 3T3-L1 adipocytes, Ang II stimulation increased aldosterone secretion and CYP11B2 expression. Ang II effects were blunted by an Ang II type 1 receptor antagonist (candesartan) and inhibitors of calcineurin (cyclosporine A and FK506) and nuclear factor of activated T-cells (VIVIT). FAD286 (aldosterone synthase inhibitor) blunted adipocyte differentiation. In candesartan-treated db/db mice (1 mg/kg per day, 4 weeks) increased plasma aldosterone, CYP11B2 expression, and aldosterone secretion were reduced. Acetylcholine-induced relaxation in db/db mesenteric arteries containing perivascular fat was improved by eplerenone (mineralocorticoid receptor antagonist) without effect in db/+ mice. Adipocytes possess aldosterone synthase and produce aldosterone in an Ang II/Ang II type 1 receptor/calcineurin/nuclear factor of activated T-cells–dependent manner. Functionally adipocyte-derived aldosterone regulates adipocyte differentiation and vascular function in an autocrine and paracrine manner, respectively. These novel findings identify adipocytes as a putative link between aldosterone and vascular dysfunction in diabetes mellitus–associated obesity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, the increased aldosterone production by adipocytes in obesity was shown to contribute to the vascular changes associated with this condition (54).”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
In the citing paper
“For instance, adipocyte-derived aldosterone has emerged as a new paradigm in linking obesity with vascular disease (54).”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
In the citing paper
“Moreover, this study revealed that adipocyte-derived aldosterone regulates vascular function in a paracrine manner.”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
In the citing paper
“Adipocytes were found to possess the components necessary for aldosterone synthesis.”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [54]
Citations
Cites
Greenstein, A. S., Khavandi, K., Withers, S., Sonoyama, K., Clancy, O., Jeziorska, M., Laing, I., Yates, A. P., Pemberton, P. W., Malik, R. A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.821181 · Cited by 616
Interaction of calcineurin with substrates and targeting proteins
Li, H., Rao, A., & Hogan, P. G. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.09.011 · Cited by 381
Guo, C., Ricchiuti, V., Lian, B. Q., Yao, T. M., Coutinho, P., Romero, J. R., Li, J., Williams, G. H., & Adler, G. K. (2008) · Circulation · doi:10.1161/circulationaha.107.748640 · Cited by 342
Pivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis
Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., & Zennaro, M.-C. (2007) · The FASEB Journal · doi:10.1096/fj.06-7970com · Cited by 337
The secretory function of adipocytes in the physiology of white adipose tissue
Wang, P., Mariman, E., Renes, J., & Keijer, J. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21386 · Cited by 318
Enhanced Aldosterone Signaling in the Early Nephropathy of Rats with Metabolic Syndrome
Nagase, M., Yoshida, S., Shibata, S., Nagase, T., Gotoda, T., Ando, K., & Fujita, T. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080944 · Cited by 247
Hirata, A., Maeda, N., Hiuge, A., Hibuse, T., Fujita, K., Okada, T., Kihara, S., Funahashi, T., & Shimomura, I. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp191 · Cited by 241
Adipogenic and lipolytic effects of chronic glucocorticoid exposure
Campbell, J. E., Peckett, A. J., D'souza, A. M., Hawke, T. J., & Riddell, M. C. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00045.2010 · Cited by 228
Body Mass Index Predicts Aldosterone Production in Normotensive Adults on a High-Salt Diet
Bentley–Lewis, R., Adler, G. K., Perlstein, T. S., Seely, E. W., Hopkins, P. N., Williams, G. H., & Garg, R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1088 · Cited by 213
Ketonen, J., Jin, S., Martonen, E., & Mervaala, E. M. A. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0661 · Cited by 209
Cited by
Sorted by citations
Items 301–373 of 373
Wei, H., Long, X., Li, M., Huang, S., Li, J., & Mo, Z. (2026) · Endocrine · doi:10.1007/s12020-026-04593-9 · Cited by 2
Should Incretin Agonist-Based Drugs be Considered for First Line Antihypertensive Therapy?
Kylies, D., Dreher, L., & Wenzel, U. O. (2026) · Current Hypertension Reports · doi:10.1007/s11906-026-01374-7 · Cited by 2
Touyz, R. M., & Montezano, A. C. I. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_51-1 · Cited by 2
Self-citationInterplay between caveolin-1 and mineralocorticoid receptor in cardiometabolic disease
Czarzasta, K., & Pojoga, L. H. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0341 · Cited by 2
Epigenomic Alterations of the Human CYP11B Gene in Adrenal Zonation
Takeda, Y., Demura, M., Yoneda, T., Karashima, S., Kometani, M., Aono, D., Konishi, S., Horike, S., Nakamura, Y., Yamazaki, Y., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211956 · Cited by 2
Aldosterone/Mineralocorticoid Receptors and Their Renal Effects
Gómez-Sánchez, C. E., Gómez-Sánchez, E. P., & Mihailidou, A. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-803247-3.00029-5 · Cited by 2
da Costa, R. M., Cerqueira, D. M., Bruder‐Nascimento, A., Alves, J. V., Awata, W. M. C., Singh, S., Kufner, A., Cifuentes-Pagano, E., Pagano, P. J., Ho, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.22.558020 · Cited by 2
Aldosterone and Diabetes Risk: An Association in Need of Mechanistic Insights
Echouffo-Tcheugui, J. B., & Dagogo-Jack, S. E. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae662 · Cited by 2
Nurhayatun, E. (2024) · Tropical biomedicine · doi:10.47665/tb.41.1.002 · Cited by 1
Aldosterone induced by chronic stress promotes pancreatic steatosis in young male rats
Pérez-Sánchez, E., Sánchez‐Solís, C. N., Morimoto, S., Corona‐Pérez, A., Martı́nez–Gómez, M., Rodríguez‐Antolín, J., Cuevas‐Romero, E., & Nicolás‐Toledo, L. (2026) · Cell and Tissue Research · doi:10.1007/s00441-025-04029-2 · Cited by 1
Link of Obesity With Primary Aldosteronism: Causal or Not?
Flack, J. M., Buhnerkempe, M., Lopez, A., & Byrd, J. B. (2026) · Hypertension · doi:10.1161/hypertensionaha.126.26227 · Cited by 1
Unveiling the role of aldosterone in metabolic dysfunction–associated steatotic liver disease
Hernández‐Rubio, A., Julián, M. T., Valassi, E., Alonso, N., & Puig‐Domingo, M. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10056-3 · Cited by 1
Renal mineralocorticoid receptor expression is reduced in lipoatrophy
Toffoli, B., Bernardi, S., Winkler, C., Carrascosa, C., Gilardi, F., & Desvergne, B. (2018) · FEBS Open Bio · doi:10.1002/2211-5463.12579 · Cited by 1
Норузбаева, А. М., Kurmanbekova, B. T., & Osmankulova, G. (2019) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2019-2-26-31 · Cited by 1
Approach to the Patient with Hypertensive Nephrosclerosis
Peixoto, A. J., & Bakris, G. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411602-3.00038-x · Cited by 1
Corticosteroid Receptors, Their Chaperones and Cochaperones: How Do They Modulate Adipogenesis?
Toneatto, J., Charó, N. L., Naselli, A., Muñoz-Bernart, M., Lombardi, A., & Piwien‐Pilipuk, G. (2014) · Nuclear Receptor Research · doi:10.11131/2014/101092 · Cited by 1
Schütten, M. T. J., Kusters, Y. H. A. M., Houben, A. J. H. M., Scheijen, J. L. J. M., van de Waarenburg, M. P. H., Schalkwijk, C. G., Joris, P. J., Plat, J., Mensink, R. P., de Leeuw, P. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01541 · Cited by 1
HO-1-derived CO Is a Regulator of Vascular Function and Metabolic Syndrome
Schragenheim, J., Maayan, O., & Abraham, N. G. (2018) · Royal Society of Chemistry eBooks · doi:10.1039/9781788013000-00059 · Cited by 1
Obesity-Hypertension Physiopathology and Treatment: A Forty-Year Retrospect
Owen, J., Morse, S., McLean, A., & Reisin, E. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-75310-2_15 · Cited by 1
Obesity-Induced Cardiovascular Complications and Therapeutic Intervention
Alam, M. J., & Banerjee, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-47336-5_2 · Cited by 2
Touyz, R. M., Montezano, A. C. I., & Rosendorff, C. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6705-2_4 · Cited by 1
Self-citationNogueira, T. R., Marreiros, C. S., & Freitas, B. D. J. E. S. D. A. (2022) · Current Nutrition & Food Science · doi:10.2174/1573401318666220203164619 · Cited by 1
Obesity-Related Aldosteronism is Associated with Adverse Cardiac Structure, Function, and AdiposityPreprint
Tsai, C., Chan, J. M., Milks, J., Ferrebus, A., Hanna, I., Mahrokhian, S., Newman, A. J., Stéfanie, P.-L. S., Marques, I. R., Foote, K., et al. (2025) · medRxiv · doi:10.1101/2025.11.12.25340075 · Cited by 1
Aldosterone and Cardiovascular Diseases
Tomaschitz, A., & Pilz, S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0509-6_12
Karashima, S. (2013) · Journal of Hypertension Open Access · doi:10.4172/2167-1095.1000130
The Effects of High Glucose Exposure on Endothelial Microparticles
Turner, M. (2017) · uO Research (University of Ottawa) · doi:10.20381/ruor-20940
Koval, S. M., Miloslavsky, D. К., Снегурская, И. А., Мысниченко, О. В., & Penkova, M. Y. (2017) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.13.5.2017.110026
Aldosterone’s Mechanism of Action
Baudrand, R. F., Pojoga, L. H., & Romero, J. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-803247-3.00010-6
The state of renin-aldosterone system in patients with resistant arterial hypertension
Оbertynska, О. H. (2019) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2019.3.168951
Mineralocorticoid Receptor and Leptin: A Dangerous Liaison in the Obese Heart
Marín‐Royo, G., Luaces, M., Cachofeiro, V., & Martínez‐Martínez, E. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.87236
Gigliotti, J. C., Le, T. H., & McDonough, A. A. (2020) · Nephrology Self-Assessment Program · doi:10.1681/nsap.2020.19.1.5
The Role of Perivascular Adipose Tissue in Arterial Function in Health and Disease
Agabiti-Rosei, C., Barp, C. G., Saxton, S. N., & Heagerty, A. M. (2020) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-030-47801-8_15
Barros, P. R. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2020.tde-24012020-115232
Mahveen, A., Ali, M. Y., & Farheen, A. (2021) · PARIPEX-INDIAN JOURNAL OF RESEARCH · doi:10.36106/paripex/9113438
Touyz, R. M., & Montezano, A. C. I. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_51 · Cited by 1
Self-citationBollag, W. B. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732664880.793544863
Delles, C., & Dominiczak, A. F. (2013) · Springer eBooks · doi:10.1007/978-88-470-5415-8_3
Obesity Hypertension: Clinical Aspects
Macumber, I. R., & Flynn, J. T. (2022) · Springer eBooks · doi:10.1007/978-3-319-31420-4_17-2
Research Progress on Related Factors Affecting Elevated Aldosterone Levels
阿达莱提, ·. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13122750
Assersen, K. B., Jensen, B. L., Enggaard, C., Vanhoutte, P. M., & Hansen, P. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-02955-8
Eccentric Vascular Remodeling: Its Relationship with Metabolic Disorders and Increased Body Mass
González, S., Brenzoni, M., Melchiori, R. E., Forcada, P. J., Alarcón, P., Svane, J. C., García, G., Ferroni, F., & Castellaro, C. (2024) · Revista Argentina de Cardiología · doi:10.7775/rac.es.v92.i1.20739
Adipocyte Aldosterone in Obstructive Sleep ApneaPreprint
Dong, Y., Bock, J. M., Karim, S., Singh, P., & Somers, V. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.07.631499
Gilyarevskiy, S. R. (2025) · Eurasian heart journal · doi:10.38109/2225-1685-2025-2-36-43
Touyz, R. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00267-3
Self-citationMaitituersun, A., Heizhati, M., Li, N., Gan, L., Li, M., Yao, L., Yang, W., Liu, S., Aierken, X., Wang, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26723990
Lin, C.-Y., Lee, H.-L., Chen, C.-W., Wang, C., Sung, F.-C., & Su, T. (2023) · Figshare · doi:10.6084/m9.figshare.22914631
Chen, S., Chen, K., Wu, J., Yang, J., Shen, L., & Yuan, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1792072
Costa, T. A., Vest, A. R., & Harrington, J. (2026) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001284
Enhance cardiovascular health through exercise
Alhajar, Y. T., Saleh, M. Y., Fathy, K. A., & Saleh, A. Y. (2026) · AIP conference proceedings · doi:10.1063/5.0321838
Modulations des atteintes cardiovasculaires et rénales dans l'insulino-résistance
Oudot, C. (2012) · theses.fr (ABES) · doi:10.70675/87f2e752za587z4efdz8695ze35f5854673b
Interactions vasculaires et hormonales dans l'hyperaldostéronisme primaire
Abdellatif, A. B. (2022) · theses.fr (ABES) · doi:10.70675/5f0b4f73zaca0z4bc4z99d5z8ca373f11d25
Ohashi, N., Uchiyama, Y., Yamashiro, Y., Ishigaki, S., Isobe, S., Ema, C., Sasaki, T., Sakakima, M., Ikegaya, N., Iwakura, T., et al. (2026) · Clinical and Experimental Nephrology · doi:10.1007/s10157-026-02871-4
Hyperaldosteronism in the Pathophysiology and Management of Cardiovascular‐Kidney‐Metabolic Syndrome
Zeitler, E. M., Klein, K. R., Lingvay, I., Pick, A., & Billings, L. K. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70781
Deng, C., Liao, H., Wu, Y., Ao, Z., & Zhang, L. (2026) · Mammalian Genome · doi:10.1007/s00335-026-10235-2
Recent Advances in the Pathophysiology of Hypertension
Montezano, A. C. I., Sarafian, R. D., Rios, F. J. O., Blaikie, Z., Camargo, L. L., Rasouli, M., & Touyz, R. M. (2026) · Physiology · doi:10.1152/physiol.00019.2023
Self-citationThe impact of mineralocorticoid receptor antagonists on fat mass and fat metabolism
Afşar, B., Afşar, R. E., & Maddukuri, G. S. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02909-0
Ideta, M. M. L., Nihei, C. M. I., MOREIRA, P. H. B., & de Freitas, A. K. E. (2025) · ABC Heart Failure & Cardiomyopathy · doi:10.36660/abchf.20250043i
Ideta, M. M. L., Nihei, C. M. I., MOREIRA, P. H. B., & de Freitas, A. K. E. (2012) · ABC Heart Failure & Cardiomyopathy · doi:10.36660/abchf.20250043
Breakthrough drugs in the treatment of hypertension-related disease
Hoshide, S., Mogi, M., Shibata, S., Kishi, T., Usui, I., Ando, H., Nakagami, H., Nishiyama, A., Kario, K., & Japanese Society of Hypertension (JSH) Working Group on Emerging Pharmacological Therapies for Hypertension Management (2026) · Hypertension Research · doi:10.1038/s41440-026-02725-2
Cardiac-Adipose Axis in Heart Failure With Preserved Ejection Fraction
Tan, R., Ma, Y. X., Li, N., Zhou, Z., Huang, Z., Liu, T. L., Liao, H., Qin, X., Li, T., & Zhang, C. (2026) · JACC Asia · doi:10.1016/j.jacasi.2026.06.006
Mineralocorticoid receptor overactivation in heart failure with preserved ejection fraction
Kobayashi, M., Pitt, B., & Zannad, F. M. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag578
Regulation of the Mineralocorticoid Receptor in Physiology and Disease
Young, M. J., Fuller, P. J., Meijer, O. C., Cole, T. J., Kanki, M., Yang, J., Ho, Q. V., Karthigan, N., & Heanue, S. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100156
Tian, Z., Willerding, J. M., Schmidt-Ott, K. M., Melk, A., & Schmidt, B. M. W. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.104176
Nassiri, S., Handoko, M. L., van de Bovenkamp, A. A., van Empel, V. P. M., van Raalte, D. H., & Eringa, E. C. (2026) · Heart Failure Reviews · doi:10.1007/s10741-026-10671-x
Sánchez‐Bayuela, T., Barrera‐Chimal, J., & Jaisser, F. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-026-01125-6
Chatterton, R. T., & Gann, P. H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1952560
Aldosterone synthase inhibitors may alter how primary care treats hypertension
Lin, P. (2026) · American Journal of Hypertension · doi:10.1093/ajh/hpag093
Aldosterone–mineralocorticoid receptor signaling and residual cardiorenal risk in type 2 diabetes
Zhao, S., Wang, C., & Ou, Y. (2026) · Acta Diabetologica · doi:10.1007/s00592-026-02811-4
UPDATES OF THE RENIN‐ANGIOTENSIN‐ALDOSTERON SYSTEM
MĂRĂNDUCA, M., Plamadeala, P., Zamosteanu, N., STOICA, B., & Stefanachi, E. (2013) · DOAJ (DOAJ: Directory of Open Access Journals)
Metadata
- Authors
- Briones, A. M., Nguyen Dinh Cat, A., Callera, G. E., Yogi, A., Burger, D., He, Y., Corrêa, J. W., Gagnon, A. M., Gomez-Sanchez, C. E., Gomez-Sanchez, E. P., Sorisky, A., Ooi, T. C., Ruzicka, M., Burns, K. D., & Touyz, R. M.
- Affiliations
- University of Ottawa (CA)
- From the Kidney Research Centre (A.M.B., A.N.D.C., G.E.C., A.Y., D.B., Y.H., J.W.C., K.D.B., R.M.T.), Chronic Disease Program (A.M.G., A.S., T.C.O.), Ottawa Hospital Research Institute, and Division of Nephrology, Department of Medicine (M.R.), University of Ottawa, Ontario, Canada; G.V. (Sonny) Montgomery Veterans Affairs and Division of Endocrinology, Department of Medicine, University of Mississippi Medical Centers, Jackson, MS (C.E.G.-S., E.P.G.-S.); Current address (A.M.B.): Departamento...
- ORCID
- Venue
- Hypertension
- Published
- 2012-05
- Volume
- 59
- Issue
- 5
- Pages
- 1069-1078
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2111017518
- Cited by
- 375
- References
- 39
- Citations by year
- 2026: 24 · 2025: 29 · 2024: 26 · 2023: 30 · 2022: 18 · 2021: 28 · 2020: 22 · 2019: 19 · 2018: 27 · 2017: 21 · 2016: 27 · 2015: 35 · 2014: 32 · 2013: 27 · 2012: 10
- FWCI
- 26.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- aldosterone synthase, calcineurin, NFAT, angiotensin II, angiotensin II type 1 receptor, adipogenesis, vascular dysfunction, db/db mice, perivascular adipose tissue, mesenteric arteries, acetylcholine-induced relaxation, mineralocorticoid receptor, candesartan, eplerenone, autocrine and paracrine signaling
- MeSH terms
- Aldosterone, Animals, Benzimidazoles, Biphenyl Compounds, Cells, Cultured, Diabetic Angiopathies, Disease Models, Animal, Humans, Mice, Inbred C57BL, Obesity, Random Allocation, Sensitivity and Specificity, Tetrazoles, Signal Transduction, Adipocytes, Calcineurin, Diabetes Complications, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review